IMP A SDB Stock Overview
Engages in the research and distribution of medical implants in Switzerland.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Implantica AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 39.65 |
52 Week High | SEK 41.50 |
52 Week Low | SEK 16.00 |
Beta | 1.27 |
11 Month Change | 4.89% |
3 Month Change | 44.71% |
1 Year Change | 97.76% |
33 Year Change | -66.40% |
5 Year Change | n/a |
Change since IPO | -58.94% |
Recent News & Updates
Recent updates
We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely
Jul 26We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely
Mar 06We Think Implantica (STO:IMP A SDB) Can Easily Afford To Drive Business Growth
Aug 19We Think Implantica (STO:IMP A SDB) Can Easily Afford To Drive Business Growth
May 05We're Not Very Worried About Implantica's (STO:IMP A SDB) Cash Burn Rate
Jan 14We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely
Sep 26Implantica (STO:IMP A SDB) Is In A Strong Position To Grow Its Business
Jan 08Shareholder Returns
IMP A SDB | SE Medical Equipment | SE Market | |
---|---|---|---|
7D | 3.0% | -1.7% | -0.6% |
1Y | 97.8% | 1.3% | 17.0% |
Return vs Industry: IMP A SDB exceeded the Swedish Medical Equipment industry which returned 3% over the past year.
Return vs Market: IMP A SDB exceeded the Swedish Market which returned 18.4% over the past year.
Price Volatility
IMP A SDB volatility | |
---|---|
IMP A SDB Average Weekly Movement | 5.6% |
Medical Equipment Industry Average Movement | 7.1% |
Market Average Movement | 5.7% |
10% most volatile stocks in SE Market | 12.1% |
10% least volatile stocks in SE Market | 3.3% |
Stable Share Price: IMP A SDB's share price has been volatile over the past 3 months.
Volatility Over Time: IMP A SDB's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2015 | 49 | Peter Forsell | www.implantica.com |
Implantica AG engages in the research and distribution of medical implants in Switzerland. The company’s lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. It is also involved in the development of eHealth platform, a digital health system to support its pipeline of smart medical implants designed for a safe and secure control and monitoring over the internet; e-InVivo, a sensor implants to monitor a multitude of health parameters and provide diagnostic information, as well as control treatment from inside the body; wireless energizing platform; and AppetiteControl, an implant to treat obesity by controlling appetite.
Implantica AG Fundamentals Summary
IMP A SDB fundamental statistics | |
---|---|
Market cap | SEK 11.23b |
Earnings (TTM) | -SEK 261.24m |
Revenue (TTM) | SEK 19.65m |
571.1x
P/S Ratio-43.0x
P/E RatioIs IMP A SDB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
IMP A SDB income statement (TTM) | |
---|---|
Revenue | €1.70m |
Cost of Revenue | €1.35m |
Gross Profit | €347.00k |
Other Expenses | €22.90m |
Earnings | -€22.56m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 21, 2024
Earnings per share (EPS) | -0.08 |
Gross Margin | 20.45% |
Net Profit Margin | -1,329.17% |
Debt/Equity Ratio | 0% |
How did IMP A SDB perform over the long term?
See historical performance and comparison